EMA Committee Recommends Approval of Lilly’s Foundayo Pill
The European Medicines Agency’s advisory committee recommended approval of Eli Lilly’s once-daily weight-loss pill, Foundayo.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
EMA Committee Recommends Approval of Eli Lilly Weight-Loss Pill
The European Medicines Agency's committee recommended approval of Eli Lilly's Foundayo, paving the way for a second oral weight-loss drug to win backing in the region after Novo Nordisk's Wegovy pill.